Metabolic Pathway Research

Metabolic research peptides target the regulatory pathways governing energy expenditure, adipogenesis, and glucose homeostasis at the cellular level. These compounds are research tools for investigating the molecular architecture of metabolic dysfunction, not weight management solutions.

AOD-9604, the C-terminal fragment of human growth hormone spanning residues 177-191, is used in lipolysis research for its selective activation of beta-3 adrenergic receptors without the IGF-1 mediated growth effects of full-length HGH. Retatrutide, a triple agonist at the GIP, GLP-1, and glucagon receptors simultaneously, represents one of the most complex incretin-based research compounds currently available. Enabling multi-pathway metabolic signaling studies from a single reagent. 5-Amino-1MQ, a selective inhibitor of Nicotinamide N-Methyltransferase (NNMT), is studied for its role in modulating NAD+ availability and adipocyte differentiation, with downstream implications for both metabolic and longevity research pathways. MOTS-c sits at the intersection of metabolic and longevity research; its influence on AMPK activation and insulin sensitization makes it relevant to both clusters.

All compounds are supplied as lyophilized powders with batch-specific HPLC and MS verification, shipped domestically within Canada with full cold-chain integrity.